Time Restricted Eating for Sleep Apnea
(TERESA Trial)
Trial Summary
What is the purpose of this trial?
Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose levels and diabetes, obesity, and nonalcoholic fatty liver. While continuous positive airway pressure (CPAP), the best available OSA treatment, has been shown to improve blood pressure in OSA, it does not appear to improve metabolic consequences of OSA, and other therapies for OSA-induced dysmetabolism are needed. Animal models of time restricted eating (TRE) demonstrate an improvement in glucose and lipid metabolism, even in the absence of a reduction of caloric intake. Some human studies have shown an improvement in metabolic dysfunction with TRE, though further well-designed studies are needed. The effects of TRE on metabolic dysfunction in patients with OSA, a population with a high predisposition to metabolic disorder, has never been examined. In this study, we will conduct a randomized clinical trial to assess the feasibility and efficacy of 12 weeks of TRE, versus standard eating (SE), to improve glucose regulation and cardiovascular health of participants with OSA.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on cardiovascular medications like statins or blood pressure drugs, you must keep the same dose during the study.
What data supports the effectiveness of the treatment Time Restricted Eating for Sleep Apnea?
Research suggests that time-restricted eating (TRE) can help reduce body weight and improve energy metabolism, which are factors that might indirectly benefit sleep apnea. Although direct effects on sleep apnea are not yet confirmed, TRE has been shown to maintain good sleep quality in people with obesity, which could be relevant for sleep apnea management.12345
Is time-restricted eating safe for humans?
How is time-restricted eating different from other treatments for sleep apnea?
Time-restricted eating (TRE) is unique because it focuses on limiting the hours during which you eat each day, aligning with your body's natural circadian rhythms, rather than using medications or devices. This approach may help improve sleep quality and energy metabolism without affecting total energy expenditure, offering a novel way to manage sleep apnea by potentially reducing body weight and improving sleep patterns.110111213
Eligibility Criteria
This trial is for adults aged 18-70 with untreated moderate to severe obstructive sleep apnea (OSA). Participants must be willing to follow the study procedures, own a smartphone, and have an eating period of over 12 hours per day. They cannot change doses of any cardiovascular medications during the study.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants maintain their current lifestyle and record dietary intake using the mCC app
Treatment
Participants follow either time restricted eating or standard eating for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Time Restricted Eating (Behavioral Intervention)